Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 9, 2009 - Issue 8
Submit an article Journal homepage
1,635
Views
28
CrossRef citations to date
0
Altmetric
Editorial

Ewing’s sarcoma origin: from duel to duality

Nicolo Riggi Division of Experimental Pathology, Institute of Pathology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland. [email protected]
,
Mario-Luca Suva Division of Experimental Pathology, Institute of Pathology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland. [email protected]
&
Ivan Stamenkovic Division of Experimental Pathology, Institute of Pathology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland. [email protected]
Pages 1025-1030 | Published online: 10 Jan 2014

Figures & data

Figure 1. Mesenchymal stem cells, by virtue of their broad plasticity, may be at the origin of different histological subtypes of human sarcomas.

MFH: Malignant fibrous histiocytoma; MSC: Mesenchymal stem cell; RMS: Rhabdomyosarcoma.

Reproduced with permission from Citation[33].

Figure 1. Mesenchymal stem cells, by virtue of their broad plasticity, may be at the origin of different histological subtypes of human sarcomas.MFH: Malignant fibrous histiocytoma; MSC: Mesenchymal stem cell; RMS: Rhabdomyosarcoma.Reproduced with permission from Citation[33].
Figure 2. Summary of the different experimental approaches used in the attempt to identify the putative cell of origin of Ewing’s sarcoma.

CSC: Cancer stem cell; ESFT: Ewing’s sarcoma family tumor; MSC: Mesenchymal stem cell.

Figure 2. Summary of the different experimental approaches used in the attempt to identify the putative cell of origin of Ewing’s sarcoma.CSC: Cancer stem cell; ESFT: Ewing’s sarcoma family tumor; MSC: Mesenchymal stem cell.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.